RBC Capital lowered the firm’s price target on Ensign Group to $112 from $114 and keeps an Outperform rating on the shares. Ensign posted solid results driven by continued occupancy improvement and easing labor pressures, and its robust robust portfolio of newly acquired assets provides a significant platform for continued organic growth, while M&A activity could pick up given more reasonable valuations, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ENSG:
- Ensign Group acquires Champions Healthcare at Willowbrook
- The Ensign Group Acquires Post Acute Care Campus in Texas
- Ensign Group price target raised to $113 from $112 at Stephens
- Ensign Group reports Q3 adjusted EPS $1.20, consensus $1.19
- The Ensign Group Reports Third Quarter 2023 Results; Raises 2023 Earnings Guidance